Recent Australian experience with hemopoietic stem and progenitor cell expansion

By Nilsson SK   Prince HM   Wall D.   Haylock DN  

Cytotherapy, Vol. 9, Iss. 3, 2007-01 ,pp. : 231-235

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Immune therapy for EBV infections after hemopoietic stem-cell transplant

By Heslop HE   Bollard CM   Gottschalk S   Kuehnle I   Huls MH   Gee AP   Brenner MK   Rooney CM  

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 433-434

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients

By Blyth Emily   Gaundar Shivashni S.   Clancy Leighton   Simms Renee M.   Bilmon Ian   Micklethwaite Kenneth P.   Gottlieb David J.  

Cytotherapy, Vol. 14, Iss. 6, 2012-07 ,pp. : 724-732

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Chondroitin Sulfate, a Major Niche Substance of Neural Stem Cells, and Cell Transplantation Therapy of Neurodegeneration Combined with Niche Modification

By  

Current Stem Cell Research & Therapy, Vol. 4, Iss. 3, 2009-09 ,pp. : 200-209

Bentham Science Publishers

Access to resources Recommend Favorite

Hemopoietic Stem-Cell Harvesting and Transplantation Using G-CSF-Primed BM: Comparison with Unprimed BM and G-CSF-Primed PBSC

By Lowenthal RM   Tuck D   Tegg E   Marsden KA   Rees B   Luck J   Ragg S   Parker N   Kotlovsky N  

Cytotherapy, Vol. 1, Iss. 5, 1999-01 ,pp. : 409-416

Ashgate Publishing Ltd

Access to resources Recommend Favorite